カテゴリー： Market Monitor Global, 世界, 医療/バイオ

代謝型グルタミン酸受容体1型の世界市場見通し2023年-2029年

◆英語タイトル：Metabotropic Glutamate Receptor 1 Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5764）◆商品コード：MMG23JU5764
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Metabotropic Glutamate Receptor 1 Market 調査レポートは次の情報を含め、グローバルにおけるの代謝型グルタミン酸受容体1型市場規模と予測を収録しています。・世界の代謝型グルタミン酸受容体1型市場：売上、2018年-2023年、2024年-2029年
・世界の代謝型グルタミン酸受容体1型市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の代謝型グルタミン酸受容体1型市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「FC-311」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

代謝型グルタミン酸受容体1型のグローバル主要企業は、Aevi Genomic Medicine Inc、 Biohaven Pharmaceutical Holding Company Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、代謝型グルタミン酸受容体1型のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の代謝型グルタミン酸受容体1型市場：タイプ別、2018年-2023年、2024年-2029年
世界の代謝型グルタミン酸受容体1型市場：タイプ別市場シェア、2022年
・FC-311、JBPOS-0101、VU-0467558、その他

世界の代謝型グルタミン酸受容体1型市場：用途別、2018年-2023年、2024年-2029年
世界の代謝型グルタミン酸受容体1型市場：用途別市場シェア、2022年
・うつ病、ディジョージ症候群、乳児けいれん、その他

世界の代謝型グルタミン酸受容体1型市場：地域・国別、2018年-2023年、2024年-2029年
世界の代謝型グルタミン酸受容体1型市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における代謝型グルタミン酸受容体1型のグローバル売上、2018年-2023年
・主要企業における代謝型グルタミン酸受容体1型のグローバル売上シェア、2022年
・主要企業における代謝型グルタミン酸受容体1型のグローバル販売量、2018年-2023年
・主要企業における代謝型グルタミン酸受容体1型のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Aevi Genomic Medicine Inc、 Biohaven Pharmaceutical Holding Company Ltd

*************************************************************

・調査・分析レポートの概要
代謝型グルタミン酸受容体1型市場の定義
市場セグメント
世界の代謝型グルタミン酸受容体1型市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の代謝型グルタミン酸受容体1型市場規模
世界の代謝型グルタミン酸受容体1型市場規模：2022年 VS 2029年
世界の代謝型グルタミン酸受容体1型市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの代謝型グルタミン酸受容体1型の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の代謝型グルタミン酸受容体1型製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：FC-311、JBPOS-0101、VU-0467558、その他
代謝型グルタミン酸受容体1型のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：うつ病、ディジョージ症候群、乳児けいれん、その他
代謝型グルタミン酸受容体1型の用途別グローバル売上・予測

・地域別市場分析
地域別代謝型グルタミン酸受容体1型市場規模 2022年と2029年
地域別代謝型グルタミン酸受容体1型売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Aevi Genomic Medicine Inc、 Biohaven Pharmaceutical Holding Company Ltd
...

This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor 1. This report contains market size and forecasts of Metabotropic Glutamate Receptor 1 in global, including the following market information:
Global Metabotropic Glutamate Receptor 1 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Metabotropic Glutamate Receptor 1 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Metabotropic Glutamate Receptor 1 companies in 2022 (%)
The global Metabotropic Glutamate Receptor 1 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
FC-311 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Metabotropic Glutamate Receptor 1 include Aevi Genomic Medicine Inc and Biohaven Pharmaceutical Holding Company Ltd etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabotropic Glutamate Receptor 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metabotropic Glutamate Receptor 1 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 1 Market Segment Percentages, by Type, 2022 (%)
FC-311
JBPOS-0101
VU-0467558
Others
Global Metabotropic Glutamate Receptor 1 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 1 Market Segment Percentages, by Application, 2022 (%)
Depression
DiGeorge Syndrome
Infantile Spasm
Others
Global Metabotropic Glutamate Receptor 1 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 1 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabotropic Glutamate Receptor 1 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Metabotropic Glutamate Receptor 1 revenues share in global market, 2022 (%)
Key companies Metabotropic Glutamate Receptor 1 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Metabotropic Glutamate Receptor 1 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aevi Genomic Medicine Inc
Biohaven Pharmaceutical Holding Company Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metabotropic Glutamate Receptor 1, market overview.
Chapter 2: Global Metabotropic Glutamate Receptor 1 market size in revenue and volume.
Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metabotropic Glutamate Receptor 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Metabotropic Glutamate Receptor 1 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Metabotropic Glutamate Receptor 1 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metabotropic Glutamate Receptor 1 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metabotropic Glutamate Receptor 1 Overall Market Size
2.1 Global Metabotropic Glutamate Receptor 1 Market Size: 2022 VS 2029
2.2 Global Metabotropic Glutamate Receptor 1 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Metabotropic Glutamate Receptor 1 Sales: 2018-2029
3 Company Landscape
3.1 Top Metabotropic Glutamate Receptor 1 Players in Global Market
3.2 Top Global Metabotropic Glutamate Receptor 1 Companies Ranked by Revenue
3.3 Global Metabotropic Glutamate Receptor 1 Revenue by Companies
3.4 Global Metabotropic Glutamate Receptor 1 Sales by Companies
3.5 Global Metabotropic Glutamate Receptor 1 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Metabotropic Glutamate Receptor 1 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Metabotropic Glutamate Receptor 1 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metabotropic Glutamate Receptor 1 Players in Global Market
3.8.1 List of Global Tier 1 Metabotropic Glutamate Receptor 1 Companies
3.8.2 List of Global Tier 2 and Tier 3 Metabotropic Glutamate Receptor 1 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Metabotropic Glutamate Receptor 1 Market Size Markets, 2022 & 2029
4.1.2 FC-311
4.1.3 JBPOS-0101
4.1.4 VU-0467558
4.1.5 Others
4.2 By Type – Global Metabotropic Glutamate Receptor 1 Revenue & Forecasts
4.2.1 By Type – Global Metabotropic Glutamate Receptor 1 Revenue, 2018-2023
4.2.2 By Type – Global Metabotropic Glutamate Receptor 1 Revenue, 2024-2029
4.2.3 By Type – Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
4.3 By Type – Global Metabotropic Glutamate Receptor 1 Sales & Forecasts
4.3.1 By Type – Global Metabotropic Glutamate Receptor 1 Sales, 2018-2023
4.3.2 By Type – Global Metabotropic Glutamate Receptor 1 Sales, 2024-2029
4.3.3 By Type – Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
4.4 By Type – Global Metabotropic Glutamate Receptor 1 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Metabotropic Glutamate Receptor 1 Market Size, 2022 & 2029
5.1.2 Depression
5.1.3 DiGeorge Syndrome
5.1.4 Infantile Spasm
5.1.5 Others
5.2 By Application – Global Metabotropic Glutamate Receptor 1 Revenue & Forecasts
5.2.1 By Application – Global Metabotropic Glutamate Receptor 1 Revenue, 2018-2023
5.2.2 By Application – Global Metabotropic Glutamate Receptor 1 Revenue, 2024-2029
5.2.3 By Application – Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
5.3 By Application – Global Metabotropic Glutamate Receptor 1 Sales & Forecasts
5.3.1 By Application – Global Metabotropic Glutamate Receptor 1 Sales, 2018-2023
5.3.2 By Application – Global Metabotropic Glutamate Receptor 1 Sales, 2024-2029
5.3.3 By Application – Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
5.4 By Application – Global Metabotropic Glutamate Receptor 1 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Metabotropic Glutamate Receptor 1 Market Size, 2022 & 2029
6.2 By Region – Global Metabotropic Glutamate Receptor 1 Revenue & Forecasts
6.2.1 By Region – Global Metabotropic Glutamate Receptor 1 Revenue, 2018-2023
6.2.2 By Region – Global Metabotropic Glutamate Receptor 1 Revenue, 2024-2029
6.2.3 By Region – Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
6.3 By Region – Global Metabotropic Glutamate Receptor 1 Sales & Forecasts
6.3.1 By Region – Global Metabotropic Glutamate Receptor 1 Sales, 2018-2023
6.3.2 By Region – Global Metabotropic Glutamate Receptor 1 Sales, 2024-2029
6.3.3 By Region – Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Metabotropic Glutamate Receptor 1 Revenue, 2018-2029
6.4.2 By Country – North America Metabotropic Glutamate Receptor 1 Sales, 2018-2029
6.4.3 US Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.4.4 Canada Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.4.5 Mexico Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Metabotropic Glutamate Receptor 1 Revenue, 2018-2029
6.5.2 By Country – Europe Metabotropic Glutamate Receptor 1 Sales, 2018-2029
6.5.3 Germany Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.4 France Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.5 U.K. Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.6 Italy Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.7 Russia Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.8 Nordic Countries Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.5.9 Benelux Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Metabotropic Glutamate Receptor 1 Revenue, 2018-2029
6.6.2 By Region – Asia Metabotropic Glutamate Receptor 1 Sales, 2018-2029
6.6.3 China Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.6.4 Japan Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.6.5 South Korea Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.6.6 Southeast Asia Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.6.7 India Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Metabotropic Glutamate Receptor 1 Revenue, 2018-2029
6.7.2 By Country – South America Metabotropic Glutamate Receptor 1 Sales, 2018-2029
6.7.3 Brazil Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.7.4 Argentina Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Metabotropic Glutamate Receptor 1 Sales, 2018-2029
6.8.3 Turkey Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.8.4 Israel Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.8.5 Saudi Arabia Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
6.8.6 UAE Metabotropic Glutamate Receptor 1 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aevi Genomic Medicine Inc
7.1.1 Aevi Genomic Medicine Inc Company Summary
7.1.2 Aevi Genomic Medicine Inc Business Overview
7.1.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Major Product Offerings
7.1.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales and Revenue in Global (2018-2023)
7.1.5 Aevi Genomic Medicine Inc Key News & Latest Developments
7.2 Biohaven Pharmaceutical Holding Company Ltd
7.2.1 Biohaven Pharmaceutical Holding Company Ltd Company Summary
7.2.2 Biohaven Pharmaceutical Holding Company Ltd Business Overview
7.2.3 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Major Product Offerings
7.2.4 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales and Revenue in Global (2018-2023)
7.2.5 Biohaven Pharmaceutical Holding Company Ltd Key News & Latest Developments
8 Global Metabotropic Glutamate Receptor 1 Production Capacity, Analysis
8.1 Global Metabotropic Glutamate Receptor 1 Production Capacity, 2018-2029
8.2 Metabotropic Glutamate Receptor 1 Production Capacity of Key Manufacturers in Global Market
8.3 Global Metabotropic Glutamate Receptor 1 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Metabotropic Glutamate Receptor 1 Supply Chain Analysis
10.1 Metabotropic Glutamate Receptor 1 Industry Value Chain
10.2 Metabotropic Glutamate Receptor 1 Upstream Market
10.3 Metabotropic Glutamate Receptor 1 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Metabotropic Glutamate Receptor 1 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Metabotropic Glutamate Receptor 1 in Global Market
Table 2. Top Metabotropic Glutamate Receptor 1 Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Metabotropic Glutamate Receptor 1 Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Metabotropic Glutamate Receptor 1 Revenue Share by Companies, 2018-2023
Table 5. Global Metabotropic Glutamate Receptor 1 Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Metabotropic Glutamate Receptor 1 Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Metabotropic Glutamate Receptor 1 Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Metabotropic Glutamate Receptor 1 Product Type
Table 9. List of Global Tier 1 Metabotropic Glutamate Receptor 1 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metabotropic Glutamate Receptor 1 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2018-2023
Table 15. By Type - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2024-2029
Table 16. By Application – Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2018-2023
Table 20. By Application - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2024-2029
Table 21. By Region – Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Metabotropic Glutamate Receptor 1 Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2018-2023
Table 25. By Region - Global Metabotropic Glutamate Receptor 1 Sales (K Pcs), 2024-2029
Table 26. By Country - North America Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Sales, (K Pcs), 2024-2029
Table 46. Aevi Genomic Medicine Inc Company Summary
Table 47. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product Offerings
Table 48. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Aevi Genomic Medicine Inc Key News & Latest Developments
Table 50. Biohaven Pharmaceutical Holding Company Ltd Company Summary
Table 51. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product Offerings
Table 52. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Biohaven Pharmaceutical Holding Company Ltd Key News & Latest Developments
Table 54. Metabotropic Glutamate Receptor 1 Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 55. Global Metabotropic Glutamate Receptor 1 Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Metabotropic Glutamate Receptor 1 Production by Region, 2018-2023 (K Pcs)
Table 57. Global Metabotropic Glutamate Receptor 1 Production by Region, 2024-2029 (K Pcs)
Table 58. Metabotropic Glutamate Receptor 1 Market Opportunities & Trends in Global Market
Table 59. Metabotropic Glutamate Receptor 1 Market Drivers in Global Market
Table 60. Metabotropic Glutamate Receptor 1 Market Restraints in Global Market
Table 61. Metabotropic Glutamate Receptor 1 Raw Materials
Table 62. Metabotropic Glutamate Receptor 1 Raw Materials Suppliers in Global Market
Table 63. Typical Metabotropic Glutamate Receptor 1 Downstream
Table 64. Metabotropic Glutamate Receptor 1 Downstream Clients in Global Market
Table 65. Metabotropic Glutamate Receptor 1 Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Metabotropic Glutamate Receptor 1 Segment by Type in 2022
Figure 2. Metabotropic Glutamate Receptor 1 Segment by Application in 2022
Figure 3. Global Metabotropic Glutamate Receptor 1 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metabotropic Glutamate Receptor 1 Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Metabotropic Glutamate Receptor 1 Revenue, 2018-2029 (US$, Mn)
Figure 7. Metabotropic Glutamate Receptor 1 Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Metabotropic Glutamate Receptor 1 Revenue in 2022
Figure 9. By Type - Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 11. By Type - Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 12. By Type - Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 15. By Application - Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 16. By Application - Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 20. By Region - Global Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 21. By Country - North America Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 22. By Country - North America Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 23. US Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 28. Germany Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 29. France Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 37. China Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 41. India Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 43. By Country - South America Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 44. Brazil Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share, 2018-2029
Figure 48. Turkey Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Metabotropic Glutamate Receptor 1 Revenue, (US$, Mn), 2018-2029
Figure 52. Global Metabotropic Glutamate Receptor 1 Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Metabotropic Glutamate Receptor 1 by Region, 2022 VS 2029
Figure 54. Metabotropic Glutamate Receptor 1 Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 代謝型グルタミン酸受容体1型の世界市場見通し2023年-2029年(Metabotropic Glutamate Receptor 1 Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • イオンチャネル型グルタミン酸受容体NMDA 2Bの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆